AbbVie Inc.’s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates ...
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
Hosted on MSN36m
AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big TodayShares of AbbVie (NYSE:ABBV) are surging 7% this morning after the pharmaceutical giant reported solid fourth quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback